BTG is a global specialist healthcare company bringing to market innovative products in specialist areas of medicine to better serve doctors and their patients. We have a portfolio of Interventional Medicine products to advance the treatment of cancer, severe emphysema, severe blood clots and varicose veins, and Specialty Pharmaceuticals that help patients overexposed to certain medications or toxins. Inspired by patient and physician needs, BTG is investing to expand its portfolio to address some of today's most complex healthcare challenges. To learn more about BTG, please visit: btgplc.com.
5
Total Investments
5
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Health Care, Pharmaceutical
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About BTG International
Recent Investments (5)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series B | •••••• | Jul 2019 | |
| Series A | •••••• | May 2006 | |
| Series C | •••••• | Aug 2004 | |
| Series A | •••••• | Apr 2004 | |
| Series A | •••••• | Feb 2004 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.